International Journal of
Reproductive Biomedicine
Sat, Jan 18, 2025
[Archive]
Volume 11, Issue 4 (6-2013)
IJRM 2013, 11(4): 339-0 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Pourkeramati F, Soltanghoraee H, Amirjannati N, Akhondi M M, Khorram Khorshid H R. Prevalence of intratubular germ cell neoplasia in cryptorchid testes of infertile men. IJRM 2013; 11 (4) :339-0
URL: http://ijrm.ir/article-1-407-en.html
URL: http://ijrm.ir/article-1-407-en.html
Fatemeh Pourkeramati1 
, Haleh Soltanghoraee * 2, Naser Amirjannati1 , Mohammad Mehdi Akhondi1 , Hamid Reza Khorram Khorshid1
, Haleh Soltanghoraee * 2, Naser Amirjannati1 , Mohammad Mehdi Akhondi1 , Hamid Reza Khorram Khorshid1
1- Reproductive Biotechnology Research Center, Avicenna Research Institute (ACECR), Tehran, Iran
2- Reproductive Biotechnology Research Center, Avicenna Research Institute (ACECR), Tehran, Iran ,soltan@avicenna.ac.ir
2- Reproductive Biotechnology Research Center, Avicenna Research Institute (ACECR), Tehran, Iran ,
Full-Text [PDF 280 kb]
(711 Downloads)
| Abstract (HTML) (2842 Views)
Full-Text: (398 Views)
Introduction
Cryptorchidism (undescended testis) is the most common congenital malformation in newborn boys (about 3% of full-term infants).Testis may be located between the abdominal cavity and immediately external to the scrotum, unilaterally or bilaterally. From all undescended testes seen after birth, mostly descend normally within a few months. Only 1% with a persisting cryptorchid condition needs for medical or surgical treatments (1).
Intratubular germ cell neoplasia (IGCN) consists of enlarged spermatogonial cells with clear large cytoplasm, irregular nuclear borders, hyperchromatic and prominent nucleoli. IGCN is the precursor of invasive germ cell tumors. Immunohistochemistry staining for placental like acid phosphatase (PLAP) shows positive results in a high percentage of IGCN, while it is almost always negative in non-neoplastic spermatogonial cells (2).
The relationship of cryptorchid testis to its late malignant transformation has been discussed in many studies. There is a risk of 30 to 50 times for malignancy occurring in an undescended testis than in a normally descended testis (3). Besides it seems that the time of orchidopexy is important in the risk of malignancy. Recent data suggest that risk of malignant degeneration may be 2-6 times higher in men underwent orchidopexy after puberty compared with those having surgery at an earlier ages (<10 years) (4, 5). Orchidopexy not only decreases the rate of malignancy but also exposes testes to be examined (6).
In some references orchiectomy is the best suggestion for post-pubertal men up to age 50 years. Because these gonads have poor fertility potential and increased risk of malignancy, whereas non-operative treatment is recommended in men older than 50 years because there is no sufficient studies to define their cancer risk (7).
Yet the orchidectomy is a challenging issue in these patients, especially in infertile men. There is no previous study in our country to show the rate of malignancy of cryptorchid testes of adult patients. There are two reports
91-10-4/Figure_1.jpg)
Figure 1. ICGN in H&E slide. These are cells with large clear cytoplasm, chromatin clumps in nuclei, irregular nuclear borders and atypical cellular shapes lined on tubular basement membrane.
91-10-4/Figure_2.jpg)
Figure 2. Positive cells (brown stained) for PLAP marker seen in these tubules proved the presence of IGCN in these tubules.
Discussion
Modern analysis suggests that the rate of prior cryptorchidism in men with testicular cancer is around 5-10% (10, 11). While an accurate estimate of the lifetime risk of testicular cancer in a man without any risk factor has often been quoted to be 1 in 500 (12). As Skakkebaek indicated testicular dysgenesis syndrome (TDS) is related to the problems such as IGCN, cryptorchidism, hypospadias and low sperm counts, caused by prenatal testicular developmental disturbance (13, 14).
Thus, in infertility clinics especially those encounter with chryptorchid patients, these risk factors should be consided. There are two studies like the present study in recent years, both in 2005: a study in Spain on 25 males from which one (4%) showed seminoma (8). In another study from Tunis 2 out of 81 (2.4%) cryptorchid patients older than the age 14, were found to have developed a testicular malignancy (9).
The invasive tumor rate in our series was 7.6% which was the same as above mentioned articles (p-value 0.67, 0.75 respectively). On the other side the prevalence of 23.08% ICGN in this study is a considerable figure, which should be mentioned in clinical evaluation of infertile men. The problem of these patients could change from seeking fertility treatment to a general health risk.
As a result of infrequency of these patients who had not undergone orchiopexy early in their life the expansion of samples was not practical. Thus we suggest more evaluation of such patients and considering them as high risk patients for malignancy beside treatment of infertility.
Acknowledgements
This study was financially supported by Avicenna Infertility Clinic, as a part of main study of "PLAP marker in testicular biopsies of infertile men" which was master degree dissertation.
Conflict of interest
There is no conflict of interest in this article.
Cryptorchidism (undescended testis) is the most common congenital malformation in newborn boys (about 3% of full-term infants).Testis may be located between the abdominal cavity and immediately external to the scrotum, unilaterally or bilaterally. From all undescended testes seen after birth, mostly descend normally within a few months. Only 1% with a persisting cryptorchid condition needs for medical or surgical treatments (1).
Intratubular germ cell neoplasia (IGCN) consists of enlarged spermatogonial cells with clear large cytoplasm, irregular nuclear borders, hyperchromatic and prominent nucleoli. IGCN is the precursor of invasive germ cell tumors. Immunohistochemistry staining for placental like acid phosphatase (PLAP) shows positive results in a high percentage of IGCN, while it is almost always negative in non-neoplastic spermatogonial cells (2).
The relationship of cryptorchid testis to its late malignant transformation has been discussed in many studies. There is a risk of 30 to 50 times for malignancy occurring in an undescended testis than in a normally descended testis (3). Besides it seems that the time of orchidopexy is important in the risk of malignancy. Recent data suggest that risk of malignant degeneration may be 2-6 times higher in men underwent orchidopexy after puberty compared with those having surgery at an earlier ages (<10 years) (4, 5). Orchidopexy not only decreases the rate of malignancy but also exposes testes to be examined (6).
In some references orchiectomy is the best suggestion for post-pubertal men up to age 50 years. Because these gonads have poor fertility potential and increased risk of malignancy, whereas non-operative treatment is recommended in men older than 50 years because there is no sufficient studies to define their cancer risk (7).
Yet the orchidectomy is a challenging issue in these patients, especially in infertile men. There is no previous study in our country to show the rate of malignancy of cryptorchid testes of adult patients. There are two reports
in other countries showing the prevalence of malignancy about 4% (8, 9). This study performed to reveal the importance of follow up of infertile cryptorchid men, not only for treatment of their infertility but also for screening for IGCN.
Materials and methods
In referral Andrology Clinic of Avicenna Infertility Center, from 2004 to 2010, 13 infertile azoospermic patients were found for whom unilateral laparascopic orchidectomy due to unpalpable intra-abdominal testis had done. This cross-sectional study was approved by Avicenna Ethics Committee, and a signed consent was given by all patients. Patients were adults with untreated cryptorchidism and no one had a history of a previous malignancy especially in testis. All the testes were obtained by laparoscopic procedure. The mean age of patients was 35.53 years (27-43 yrs). Testicular samples were fixed overnight in Bouin’s fixative, directly after orchidectomy and subsequently embedded in paraffin. Two tissue sections were prepared from each sample then stained with Heamatoxylin and Eosin (H&E) (Figure 1) and immunohistochemistry staining of placental alkaline phosphatase (PLAP), which is routinely used as an IGCN marker.
The immunohistochemical staining was performed using a standard indirect peroxidase method. Briefly, the dewaxed and rehydrated sections were heated in a microwave oven in a 10 mmol/l citrate buffer, pH=6.0 to unmask the antigen. Subsequently, the sections were incubated with H2O2 to inhibit the endogenous peroxidase, followed by protein block to block unspecific binding sites (Novocastra kit, RE7140-k).
The incubation with the primary PLAP mouse monoclonal antibody (Novocastra antibody, NCL-PLAP-8A9) diluted 1:20 was carried out for 40 minutes at room temperature. Subsequently, a HRP-anti-mouse link antibody was applied and visualized using DAB (diluted 1:20). Sections were then thoroughly washed. For negetive control, negetive tissue (tonsil) was used. Sections were counterstained with Mayer’s Haematoxylin to mark unstained nuclei. The sections were examined under light microscope by two pathologists (Figure 2).
Statistical analysis
We used Minitab 14 software and two proportions test to compare our results with other articles (H0: P1=P2).
Results
Ten out of 13 assessed testes were left testis. The macroscopic evaluation and measurements revealed volume of testes between 2.4-24.75 ml. In H&E slides one of the samples showed seminoma besides IGCN and two slides had only IGCN. Immunohistochemistry for PLAP as a marker of IGCN proved the H&E findings, thus IGCN in examined testes corresponding to a prevalance of 23.08% while the invasive tumor rate was 7.6%. The mean volume of involved testes was 20.17 ml and the volume for testes without IGCN was 9.63 ml. Two out of three involved testes were left side. Age of patients having IGCN in their testis was between 32-37 years.
Materials and methods
In referral Andrology Clinic of Avicenna Infertility Center, from 2004 to 2010, 13 infertile azoospermic patients were found for whom unilateral laparascopic orchidectomy due to unpalpable intra-abdominal testis had done. This cross-sectional study was approved by Avicenna Ethics Committee, and a signed consent was given by all patients. Patients were adults with untreated cryptorchidism and no one had a history of a previous malignancy especially in testis. All the testes were obtained by laparoscopic procedure. The mean age of patients was 35.53 years (27-43 yrs). Testicular samples were fixed overnight in Bouin’s fixative, directly after orchidectomy and subsequently embedded in paraffin. Two tissue sections were prepared from each sample then stained with Heamatoxylin and Eosin (H&E) (Figure 1) and immunohistochemistry staining of placental alkaline phosphatase (PLAP), which is routinely used as an IGCN marker.
The immunohistochemical staining was performed using a standard indirect peroxidase method. Briefly, the dewaxed and rehydrated sections were heated in a microwave oven in a 10 mmol/l citrate buffer, pH=6.0 to unmask the antigen. Subsequently, the sections were incubated with H2O2 to inhibit the endogenous peroxidase, followed by protein block to block unspecific binding sites (Novocastra kit, RE7140-k).
The incubation with the primary PLAP mouse monoclonal antibody (Novocastra antibody, NCL-PLAP-8A9) diluted 1:20 was carried out for 40 minutes at room temperature. Subsequently, a HRP-anti-mouse link antibody was applied and visualized using DAB (diluted 1:20). Sections were then thoroughly washed. For negetive control, negetive tissue (tonsil) was used. Sections were counterstained with Mayer’s Haematoxylin to mark unstained nuclei. The sections were examined under light microscope by two pathologists (Figure 2).
Statistical analysis
We used Minitab 14 software and two proportions test to compare our results with other articles (H0: P1=P2).
Results
Ten out of 13 assessed testes were left testis. The macroscopic evaluation and measurements revealed volume of testes between 2.4-24.75 ml. In H&E slides one of the samples showed seminoma besides IGCN and two slides had only IGCN. Immunohistochemistry for PLAP as a marker of IGCN proved the H&E findings, thus IGCN in examined testes corresponding to a prevalance of 23.08% while the invasive tumor rate was 7.6%. The mean volume of involved testes was 20.17 ml and the volume for testes without IGCN was 9.63 ml. Two out of three involved testes were left side. Age of patients having IGCN in their testis was between 32-37 years.
Figure 1. ICGN in H&E slide. These are cells with large clear cytoplasm, chromatin clumps in nuclei, irregular nuclear borders and atypical cellular shapes lined on tubular basement membrane.
Figure 2. Positive cells (brown stained) for PLAP marker seen in these tubules proved the presence of IGCN in these tubules.
Discussion
Modern analysis suggests that the rate of prior cryptorchidism in men with testicular cancer is around 5-10% (10, 11). While an accurate estimate of the lifetime risk of testicular cancer in a man without any risk factor has often been quoted to be 1 in 500 (12). As Skakkebaek indicated testicular dysgenesis syndrome (TDS) is related to the problems such as IGCN, cryptorchidism, hypospadias and low sperm counts, caused by prenatal testicular developmental disturbance (13, 14).
Thus, in infertility clinics especially those encounter with chryptorchid patients, these risk factors should be consided. There are two studies like the present study in recent years, both in 2005: a study in Spain on 25 males from which one (4%) showed seminoma (8). In another study from Tunis 2 out of 81 (2.4%) cryptorchid patients older than the age 14, were found to have developed a testicular malignancy (9).
The invasive tumor rate in our series was 7.6% which was the same as above mentioned articles (p-value 0.67, 0.75 respectively). On the other side the prevalence of 23.08% ICGN in this study is a considerable figure, which should be mentioned in clinical evaluation of infertile men. The problem of these patients could change from seeking fertility treatment to a general health risk.
As a result of infrequency of these patients who had not undergone orchiopexy early in their life the expansion of samples was not practical. Thus we suggest more evaluation of such patients and considering them as high risk patients for malignancy beside treatment of infertility.
Acknowledgements
This study was financially supported by Avicenna Infertility Clinic, as a part of main study of "PLAP marker in testicular biopsies of infertile men" which was master degree dissertation.
Conflict of interest
There is no conflict of interest in this article.
Type of Study: Original Article |
References
1. Trussell JC, Lee PA. The relationship of cryptorchidism to fertility. Curr Urol Rep 2004; 5: 142-148. [DOI:10.1007/s11934-004-0028-4]
2. Montironi R. Intratubular Germ Cell Neoplasia of the Testis: Testicular Intraepithelial Neoplasia. Eur Urol 2002; 41: 651-654. [DOI:10.1016/S0302-2838(02)00046-5]
3. Batata MA, Whitmore WFJ, Hilaris BS, Tokita N, Grabstald H. Cancer of the undescended testis. Am J Roentgen 1976; 126: 302. [DOI:10.2214/ajr.126.2.302]
4. Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O. Age at surgery for undescended testis and risk of testicular cancer. New Eng J Med 2007; 356: 1835-1841. [DOI:10.1056/NEJMoa067588]
5. Walsh TJ, Dall'Era MA, Croughan MS, Carroll PR, Turek PJ. Prepubertal orchiopexy for cryptorchidism may be associated with lower risk of testicular cancer. J Urol 2007; 178: 1440-1446. [DOI:10.1016/j.juro.2007.05.166]
6. Chiba K, Ishikawa T, Yamaguchi K, Fujisawa M. The efficacy of adult orchidopexy as a treatment of male infertility: our experience of 20 cases. Fertil Steril 2009; 92: 1337-1339. [DOI:10.1016/j.fertnstert.2009.03.104]
7. Wood HM, Elder JS. Cryptorchidism and testicular cancer: separating fact from fiction. J Urol 2009; 181: 452-461. [DOI:10.1016/j.juro.2008.10.074]
8. Granados EA, Loarca SEO. Is necessary to practice orchiectomy in patients with post-puberal maldescended testes? Actas Urol Esp 2005; 29: 969-973.
9. Ben Jeddou F, Ghozzi S, Rais NB. [Cryptorchidism in adults. About 81 cases]. La Tunisie medicale 2005; 83: 742-745.
10. Kanto S, Hiramatsu M, Suzuki K, Ishidoya S, Saito H, Yamada S. Risk factors in past histories and familial episodes related to development of testicular germ cell tumor. Int J Urol 2004; 11: 640. [DOI:10.1111/j.1442-2042.2004.00853.x]
11. Prener A, Engholm G, Jensen O. Genital anomalies and risk for testicular cancer in Danish men. Epidemiology 1996; 7: 14. [DOI:10.1097/00001648-199601000-00004]
12. Wood HM, Elder JS. Cryptorchidism and Testicular Cancer: Separating Fact From Fiction. J Urol 2009; 181: 452-461. [DOI:10.1016/j.juro.2008.10.074]
13. Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 2001; 16: 972-978. [DOI:10.1093/humrep/16.5.972]
14. Skakkebaek NE. Carcinoma in situ of the testis: frequency and relationship to invasive germ cell tumours in infertile men. N. E. Skakkebaek. Histopathology 1978; 2; 157-170. Histopathology 2002; 41: 2-3. [DOI:10.1046/j.1365-2559.2002.14771.x]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
